Compare SHC & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHC | CPRI |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 2.4B |
| IPO Year | 2020 | 2011 |
| Metric | SHC | CPRI |
|---|---|---|
| Price | $18.24 | $14.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 16 |
| Target Price | ★ $22.72 | $22.22 |
| AVG Volume (30 Days) | 1.5M | ★ 4.3M |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 68.75 | ★ 111.40 |
| EPS | 0.28 | ★ 0.60 |
| Revenue | $1,163,617,000.00 | ★ $3,474,000,000.00 |
| Revenue This Year | $7.16 | N/A |
| Revenue Next Year | $5.94 | $2.79 |
| P/E Ratio | $66.16 | ★ $24.38 |
| Revenue Growth | ★ 5.74 | N/A |
| 52 Week Low | $13.09 | $12.40 |
| 52 Week High | $19.85 | $28.27 |
| Indicator | SHC | CPRI |
|---|---|---|
| Relative Strength Index (RSI) | 46.37 | 45.98 |
| Support Level | $18.19 | $12.40 |
| Resistance Level | $18.55 | $16.05 |
| Average True Range (ATR) | 0.41 | 0.68 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 20.53 | 18.43 |
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.